Dobutamine Hydrochloride Injection 49745-95-1

• Post Date:

  Dec 17,2024

• Expiry Date:

  Jun 15,2025

• Detailed Description:

  Cas No. :49745-95-1

  It is a derivative of dopamine with prominent beta one receptor activity and negligible chronotropic and peripheral vascular activity.

  Composition :	250mg/5 ml
  Indications :	Refractory chronic congestive heart failure not responding to digoxin. For inotropic support in bacteremic shock.
  Contraindications :	Acute myocardial infarction.
  Safety Profile :	Thrombocytopenia, platelet dysfunction, uncontrolled hypertension, diabetic retinopathy, and pregnancy
  Adverse Effects :	Increase in HR, BP.
  Drug Interactions :	Nitroprusside.
  Dosage :	2.5 to 10 mcg/kg in 5% dextrose by slow iv infusion.
  Purity :	Not less than 99%.

• CAS Registry Number:

  49745-95-1

• Synonyms:

  ;Dobutamine Hydrochloride;4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol hydrochloride (1:1);benzene-1,2-diol hydrochloride;

• Molecular Formula:

  C₆H₇ClO₂

• Molecular Weight:

  146.5716

• Molecular Structure:

  

• Hazard Symbols:

   Xn:Harmful;
  

• Risk Codes:

  R20/21/22:;
  R63:;
  

• Safety Description:

  S22:;
  S26:;
  S36/37/39:;
  

• Company:

  Shanghai DND Pharm-Technology Co., Inc.     [ China ]          

• Contact:

  Arron Yu

• Tel:

  021-58783620

• Fax:

  021-58783595

• Email:

  sales@dndpharm.com